Clinical Trial

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

Study acronym: CGM QOL
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-02.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT06965803
Lead Sponsor Cedars-Sinai Medical Center
Conditions Diabetes Mellitus
Enrollment 37 participants
Start Date 2025-10-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-18